Literature DB >> 21234697

Living post treatment: definitions of those with history and no history of cancer.

Kimberly M Kelly1, Neel Shah, Randi Shedlosky-Shoemaker, Kyle Porter, Doreen Agnese.   

Abstract

INTRODUCTION: Breast cancer is the leading cause of cancer, and the second leading cause of cancer death in women. Due to advances in medicine, the 10 year survival rate is 80%, resulting in a large and growing number of breast cancer survivors. Definitions of cancer survivorship from a number of professional organizations and researchers vary, but the research is scant on the meaning of cancer survivorship to people with and without a prior cancer history.
METHODS: Two studies were conducted (1) to compare individuals with and without a prior personal cancer diagnosis in terms of those who identified as survivors vs. those who did not identify as survivors and (2) to explore explanations of those with and without a prior personal cancer for the term cancer survivor. In Study 1, individuals were surveyed at cancer-themed community health fairs. In Study 2, women were surveyed at a breast oncology clinic.
RESULTS: In Study 1 comparing those with and without a prior cancer diagnosis, prior cancer history was the best predictor of survivorship identity, and only three individuals without a prior cancer history included family and friends as survivors. In Study 2 of those with a personal history, longer time since diagnosis, type of cancer (ductal), and comparative risk (higher) were associated with survivor identity.
CONCLUSION: Completion of treatment was seen as a 'rite of passage', and thus, may be seen as a shift from the patient identity, which may have negative connotations, to the positive identity of survivor. IMPLICATIONS: Definitions of survivorship vary considerably, and caution should be used when applying the term to those who have no prior personal cancer diagnosis and to those who have had a more recent cancer diagnosis with a more severe disease course.

Entities:  

Mesh:

Year:  2011        PMID: 21234697     DOI: 10.1007/s11764-010-0167-1

Source DB:  PubMed          Journal:  J Cancer Surviv        ISSN: 1932-2259            Impact factor:   4.442


  20 in total

1.  Using the common sense model to understand perceived cancer risk in individuals testing for BRCA1/2 mutations.

Authors:  Kimberly Kelly; Howard Leventhal; Michael Andrykowski; Deborah Toppmeyer; Judy Much; James Dermody; Monica Marvin; Jill Baran; Marvin Schwalb
Journal:  Psychooncology       Date:  2005-01       Impact factor: 3.894

2.  What's in a name: who is a cancer survivor?

Authors:  Renee Twombly
Journal:  J Natl Cancer Inst       Date:  2004-10-06       Impact factor: 13.506

Review 3.  Informational and emotional needs of long-term survivors of breast cancer.

Authors:  Cristina García Vivar; Anne McQueen
Journal:  J Adv Nurs       Date:  2005-09       Impact factor: 3.187

4.  Younger women at increased risk for breast cancer: perceived risk, psychological well-being, and surveillance behavior.

Authors:  C Lerman; K Kash; M Stefanek
Journal:  J Natl Cancer Inst Monogr       Date:  1994

Review 5.  Cancer survivorship: a consumer movement.

Authors:  S Leigh
Journal:  Semin Oncol       Date:  1994-12       Impact factor: 4.929

Review 6.  Survivorship and discourses of identity.

Authors:  Miles Little; Kim Paul; Christopher F C Jordens; Emma-Jane Sayers
Journal:  Psychooncology       Date:  2002 Mar-Apr       Impact factor: 3.894

Review 7.  Cancer survivor identity and quality of life.

Authors:  B J Zebrack
Journal:  Cancer Pract       Date:  2000 Sep-Oct

8.  Loss of self: a fundamental form of suffering in the chronically ill.

Authors:  K Charmaz
Journal:  Sociol Health Illn       Date:  1983-07

9.  Information seeking and intentions to have genetic testing for hereditary cancers in rural and Appalachian Kentuckians.

Authors:  Kimberly M Kelly; James E Andrews; Donald O Case; Suzanne L Allard; J David Johnson
Journal:  J Rural Health       Date:  2007       Impact factor: 4.333

10.  Promotion of cancer family history awareness: Jameslink Cancer Risk Assessment Tool at community health fairs.

Authors:  Kimberly M Kelly; Kyle Porter; Amber Remy; Judith A Westman
Journal:  J Genet Couns       Date:  2008-05-17       Impact factor: 2.537

View more
  7 in total

1.  The salience of cancer and the "survivor" identity for people who have completed acute cancer treatment: a qualitative study.

Authors:  Katherine Clegg Smith; Ann C Klassen; Kisha I Coa; Susan M Hannum
Journal:  J Cancer Surviv       Date:  2015-10-13       Impact factor: 4.442

2.  A phoenix rising: who considers herself a "survivor" after a diagnosis of breast cancer?

Authors:  Christina H Jagielski; Sarah T Hawley; Kimberly Corbin; Marisa C Weiss; Jennifer J Griggs
Journal:  J Cancer Surviv       Date:  2012-08-31       Impact factor: 4.442

Review 3.  Are you a cancer survivor? A review on cancer identity.

Authors:  Sze Yan Cheung; Paul Delfabbro
Journal:  J Cancer Surviv       Date:  2016-02-11       Impact factor: 4.442

Review 4.  Epigenetic therapy for breast cancer.

Authors:  Feng-Feng Cai; Corina Kohler; Bei Zhang; Ming-Hong Wang; Wei-Jie Chen; Xiao-Yan Zhong
Journal:  Int J Mol Sci       Date:  2011-07-11       Impact factor: 5.923

5.  Interventions to improve physical activity in colorectal cancer survivors: protocol for a systematic review and meta-analysis of randomized controlled trials.

Authors:  Yves Paul Vincent Mbous; Rowida Mohamed; George A Kelley; Kimberly Michelle Kelly
Journal:  J Adv Nurs       Date:  2021-05-10       Impact factor: 3.057

Review 6.  Patient, client, consumer, survivor or other alternatives? A scoping review of preferred terms for labelling individuals who access healthcare across settings.

Authors:  Daniel S J Costa; Rebecca Mercieca-Bebber; Stephanie Tesson; Zac Seidler; Anna-Lena Lopez
Journal:  BMJ Open       Date:  2019-03-07       Impact factor: 2.692

7.  "Still a Cancer Patient"-Associations of Cancer Identity With Patient-Reported Outcomes and Health Care Use Among Cancer Survivors.

Authors:  Melissa S Y Thong; Eva-Maria Wolschon; Lena Koch-Gallenkamp; Annika Waldmann; Mechthild Waldeyer-Sauerland; Ron Pritzkuleit; Heike Bertram; Hiltraud Kajüter; Andrea Eberle; Bernd Holleczek; Sylke R Zeissig; Hermann Brenner; Volker Arndt
Journal:  JNCI Cancer Spectr       Date:  2018-07-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.